Vala Sciences is a biotechnology startup founded in 2004 with the slogan "Vala enables precision drug discovery with fully automated analysis of hiPSC single-cell kinetics." The company aims to revolutionize precision drug discovery by providing advanced in vitro insights into human cell behavior in response to drug compounds. Vala Sciences offers expert services in cardiac biology and neuroscience, utilizing their proprietary Kinetic Image Cytometer (KIC®) and Structured Illumination Microscopy (SIM) platforms for detailed cellular analysis. The company's dedication to reducing avoidable clinical failures is evident in their commitment to providing accurate, cost-effective screens for drug candidates with a high probability of clinical success and low probability of side effects. Additionally, Vala Sciences provides varied and validated high content screening services that quantify the effects of compound libraries on a number of target molecules. Vala Sciences' collaboration with Scientist.com further solidifies its presence in the biotechnology sector, positioning the company as a registered supplier on the platform. With its comprehensive approach to drug discovery and commitment to leveraging advanced technology, Vala Sciences stands as a promising player in the biotechnology industry, offering potential opportunities for future investment and growth.
There is no investment information
No recent news or press coverage available for Vala Sciences.